Showing results (31-40 of 119) with videos related to
Sort By:
Pageof 12
Blood|August 8, 2008
The phagocytes: neutrophils and monocytesDavid C Dale, Laurence Boxer, W Conrad LilesJournal of Pediatric Hematology/Oncology|March 6, 2009
Revisiting the use of granulocyte transfusions in pediatric oncology patientsAlan S Graham, Thomas H Price, Thomas V BroganHuman Gene Therapy|August 1, 2012
Repeated lentivirus-mediated granulocyte colony-stimulating factor administration to treat canine cyclic neutropeniaOfer Yanay, David C Dale, William R A OsborneJournal of Clinical Apheresis|July 17, 2013
The use of 50% albumin/plasma replacement fluid in therapeutic plasma exchange for thrombotic thrombocytopenic purpuraKerry L O'Brien, Thomas H Price, Camille Howell, et al.Hematology. American Society of Hematology. Education Program|November 10, 2001
Inherited Neutrophil Disorders: Molecular Basis and New TherapiesMary C. Dinauer, Julie A. Lekstrom-Himes, David C. DaleJournal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 20, 2007
Impact of primary prophylaxis with granulocyte colony-stimulating factor on febrile neutropenia and mortality in adult cancer patients receiving chemotherapy: a systematic reviewNicole M Kuderer, David C Dale, Jeffrey Crawford, et al.Journal of the National Comprehensive Cancer Network : JNCCN|September 19, 2009
Myelotoxicity and dose intensity of chemotherapy: reporting practices from randomized clinical trialsDavid C Dale, Gordon C McCarter, Jeffrey Crawford, et al.Blood|January 18, 2003
Transfusion-transmitted cytomegalovirus infection after receipt of leukoreduced blood productsW Garrett Nichols, Thomas H Price, Ted Gooley, et al.Breast Cancer Research and Treatment|June 18, 2013
A retrospective evaluation of chemotherapy dose intensity and supportive care for early-stage breast cancer in a curative settingGary H Lyman, David C Dale, Dianne Tomita, et al.Leukemia & Lymphoma|May 1, 2015
Changing patterns of chemotherapy relative dose intensity and supportive care for aggressive B-cell non-Hodgkin lymphomaGary H Lyman, Jeffrey Crawford, Dianne Tomita, et al.Pageof 12